Sofokast 400 (Sofosbuvir Tablet) 400mg

Sofokast 400 is a prescription antiviral tablet containing 400mg sofosbuvir, used to treat chronic hepatitis C infections. This medication works by interfering with the virus’s ability to replicate. Always consult a healthcare professional for proper diagnosis and treatment guidance.

Strength

400mg

Manufacturer / TM Owner

NATCO PHARMA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sofokast 400 (sofosbuvir 400mg) is primarily used to treat chronic hepatitis C virus (HCV) infections in adults. It is often prescribed as part of a combination therapy to reduce viral load and improve liver function. This medication may also be used in certain cases to address other HCV-related conditions as determined by a doctor.

Side Effects

Sofokast 400 works by slowing the growth of the hepatitis C virus in the body, which may help reduce liver damage over time. Patients may notice improved energy levels and liver function tests as treatment progresses. Individual responses can vary based on the specific HCV genotype and overall health.

Precautions & Warnings

Store Sofokast 400 at room temperature, away from moisture and direct sunlight. Keep this medication out of reach of children and pets. Do not use if the packaging is damaged or the tablets appear discolored. Always follow the storage instructions provided with the product.

Avoid Interactions

Sofokast 400 may interact with certain medications, including some anticonvulsants, rifamycins, and HIV protease inhibitors. Combining it with herbal supplements like St. John’s Wort could reduce its effectiveness. Always inform your healthcare provider about all medications and supplements you are taking before starting treatment.

References

Frequently Asked Questions

Sofokast 400 is used to treat chronic hepatitis C virus (HCV) infections in adults, typically as part of a combination therapy.

Store Sofokast 400 at room temperature, away from moisture and direct sunlight, and keep it out of reach of children.

Consult a healthcare provider before taking Sofokast 400 with other medications, as certain drugs may interact with it.

If you miss a dose, take it as soon as you remember. If it’s almost time for the next dose, skip the missed one and continue with your regular schedule.

Common side effects may include fatigue, headache, nausea, or insomnia, but these vary by individual.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.